iCCS

Guidelines

Description

The 2023 release is an updated version of the iCCS app, a platform to deliver the top CCS Guidelines and Knowledge Translation tools in one single location.

The initial launch includes the following Guidelines:
Peripheral Arterial Disease (2022)
Heart Failure (2017, 2020, 2021)
Dyslipidemia (2021)
Atrial Fibrillation (2020)
Drive & Fly (2003, 2012)

Along with the full text of the Guidelines, you'll find an assortment of related resources including infographics, educational webinars and slide sets, pocket guides, summary sheets, and other tools.

Additional CCS Guidelines will be added over time.
Hide Show More...

Screenshots

iCCS FAQ

  • Is iCCS free?

    Yes, iCCS is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is iCCS legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does iCCS cost?

    iCCS is free.

  • What is iCCS revenue?

    To get estimated revenue of iCCS app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History

iCCS Reviews

No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
254
Top Free
407

Keywords

iCCS Installs

Last 30 days

iCCS Revenue

Last 30 days

iCCS Revenue and Downloads

Gain valuable insights into iCCS performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.